DNA VACCINE FOOTNOTE. This approach is actually not new, and was an unwanted byproduct of early gene therapy. Pharma has largely taken a backseat approach to DNA vaccines, and frankly it takes a luminary like Venter and a forward looking agency like DARPA to propel it into the limelight. At last.